1. Home
  2. PBH vs NCNO Comparison

PBH vs NCNO Comparison

Compare PBH & NCNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBH
  • NCNO
  • Stock Information
  • Founded
  • PBH 1996
  • NCNO 2011
  • Country
  • PBH United States
  • NCNO United States
  • Employees
  • PBH N/A
  • NCNO N/A
  • Industry
  • PBH Biotechnology: Pharmaceutical Preparations
  • NCNO Computer Software: Prepackaged Software
  • Sector
  • PBH Health Care
  • NCNO Technology
  • Exchange
  • PBH Nasdaq
  • NCNO Nasdaq
  • Market Cap
  • PBH 4.0B
  • NCNO 4.7B
  • IPO Year
  • PBH 2005
  • NCNO 2020
  • Fundamental
  • Price
  • PBH $84.17
  • NCNO $40.45
  • Analyst Decision
  • PBH Strong Buy
  • NCNO Buy
  • Analyst Count
  • PBH 3
  • NCNO 11
  • Target Price
  • PBH $83.67
  • NCNO $38.82
  • AVG Volume (30 Days)
  • PBH 306.9K
  • NCNO 1.0M
  • Earning Date
  • PBH 11-07-2024
  • NCNO 12-04-2024
  • Dividend Yield
  • PBH N/A
  • NCNO N/A
  • EPS Growth
  • PBH N/A
  • NCNO N/A
  • EPS
  • PBH 4.10
  • NCNO N/A
  • Revenue
  • PBH $1,110,659,000.00
  • NCNO $506,125,000.00
  • Revenue This Year
  • PBH $1.57
  • NCNO $15.92
  • Revenue Next Year
  • PBH $2.54
  • NCNO $15.48
  • P/E Ratio
  • PBH $20.41
  • NCNO N/A
  • Revenue Growth
  • PBH N/A
  • NCNO 13.64
  • 52 Week Low
  • PBH $56.61
  • NCNO $27.47
  • 52 Week High
  • PBH $84.21
  • NCNO $43.20
  • Technical
  • Relative Strength Index (RSI)
  • PBH 80.59
  • NCNO 62.45
  • Support Level
  • PBH $80.35
  • NCNO $39.55
  • Resistance Level
  • PBH $83.83
  • NCNO $43.20
  • Average True Range (ATR)
  • PBH 2.00
  • NCNO 1.03
  • MACD
  • PBH 0.34
  • NCNO -0.31
  • Stochastic Oscillator
  • PBH 99.13
  • NCNO 58.89

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflow and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans and manage the entire loan life cycle, open deposits, and other accounts and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. Ncino generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

Share on Social Networks: